New research indicates that people who stop using new slimming jabs like Wegovy and Mounjaro can put back on reduced body mass at a significantly accelerated pace than those who end traditional diet and exercise plans.
Findings released in a major medical journal demonstrates that while overweight individuals often shed about a fifth of their total mass while undergoing treatment, the weight returns at an estimated rate of 0.8 kg per month after stopping.
"People purchasing these medications should be cognizant of the danger of quick rebound weight gain when the medication concludes," stated lead investigator Dr. Susan Jebb.
That rate of recovery implies a reversion to starting weight within about one and a half years.
Comparing Therapies
The research, which reviewed 37 of studies involving thousands of patients, contrasted the results of the injectable medications with conventional dieting.
Scientists note that people who lose weight through diet and exercise typically have a more gradual creep back—perhaps 0.1 kg a month—post-intervention.
Explaining the Quick Rebound
Experts suggest the mode of action of the injections accounts for the accelerated rebound.
The injections copy a body's own chemical called GLP-1, which moderates feelings of fullness.
"Artificially providing GLP-1 levels far above than the body's typical production may cause the system to produce less of its endogenous hormone, and could reduce sensitivity to its actions," said Dr. Adam Collins, a dietetics expert.
"Discontinuation of this hormone supplement means hunger is uncontrolled, making excessive eating a significant risk."
An Ongoing Disease?
Health authorities recommend the injections for individuals with obesity-related health risks, accompanied by recommended lifestyle changes.
A number of clinicians argue that, due to the likelihood of weight regain, the treatment might need to be long-term.
This perspective is supported by pharmaceutical companies, who state that the findings "highlight the long-term character of obesity," akin to managing conditions like hypertension.
User Accounts
Users who have stopped the medication explain a intense resurgence of cravings.
"I experienced a switch flipping and you're instantly starving," recalled a patient.
The struggle is worsened if users have not adopted lasting dietary or behavioural changes during treatment.
Widespread Interest
Recent estimates suggest that millions of adults in the UK have tried weight-loss jabs in the past year, with desire remaining high.
- Use is greater among females compared to men.
- The middle-aged demographic shows the highest usage rates.
- A large proportion access the drugs through private prescriptions rather than the NHS.
In conclusion, experts caution that while GLP-1 drugs are potent tools for shedding pounds, they are not a magic solution and maintained weight loss relies on ongoing lifestyle changes.
